financetom
Business
financetom
/
Business
/
UniFirst's Fiscal Q2 Earnings, Revenue Rise; Provides Fiscal 2025 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UniFirst's Fiscal Q2 Earnings, Revenue Rise; Provides Fiscal 2025 Guidance
Apr 2, 2025 5:54 AM

08:20 AM EDT, 04/02/2025 (MT Newswires) -- UniFirst ( UNF ) reported fiscal Q2 earnings Wednesday of $1.31 per diluted share, up from $1.09 a year earlier.

Analysts surveyed by FactSet expected $1.34.

Revenue for the quarter ended March 1 was $602.2 million, up from $590.7 million a year earlier.

Three analysts polled by FactSet expected $602.8 million.

For fiscal 2025, the company said it expects EPS of $7.30 to $7.70. Analysts polled by FactSet expect $7.77.

Revenue for the fiscal year is projected to be between $2.422 billion and $2.432 billion. Three analysts polled by FactSet expect $2.43 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chevron accelerates Kazakh oilfield ramp-up, sources say
Chevron accelerates Kazakh oilfield ramp-up, sources say
Feb 7, 2025
* Chevron ( CVX ) expected full capacity of Tengiz expansion by June * Output at Tengiz jumped to 900,000 bpd in early February - data * Kazakhstan frequently overproduces under OPEC+ deal Feb 7 (Reuters) - Chevron ( CVX ) is speeding up its expansion of Kazakhstan's Tengiz oilfield, two sources familiar with the plans told Reuters, raising its...
Fennec Pharmaceuticals Announces Commercial Launch of Pedmarqsi in Germany
Fennec Pharmaceuticals Announces Commercial Launch of Pedmarqsi in Germany
Feb 7, 2025
08:03 AM EST, 02/07/2025 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) on Friday said Norgine Pharmaceuticals has commercially launched Pedmarqsi (sodium thiosulfate injection) in Germany. Fennec, which last March granted Norgine the right to commercialize Pedmarqsi in Europe, Australia and New Zealand, received $43 million in an upfront payment. It will also receive up to $230 million in commercial...
Fennec Pharmaceuticals' Pedmarqsi Launched in Germany by Norgine Pharmaceuticals
Fennec Pharmaceuticals' Pedmarqsi Launched in Germany by Norgine Pharmaceuticals
Feb 7, 2025
08:00 AM EST, 02/07/2025 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) said Friday that Norgine Pharmaceuticals has commercially launched Pedmarqsi in Germany as part of a licensing deal forged last year between the two companies. Under the terms of the deal, Fennec said it received an upfront payment of about $43 million and expects to receive up to approximately...
BRIEF-Prairie Operating Announces Acquisition of DJ Basin Assets from Bayswater Exploration and Production for Approximately $600 Million
BRIEF-Prairie Operating Announces Acquisition of DJ Basin Assets from Bayswater Exploration and Production for Approximately $600 Million
Feb 7, 2025
Feb 7 (Reuters) - Prairie Operating Co ( PROP ): * PRAIRIE OPERATING CO. ( PROP ) ANNOUNCES ACQUISITION OF DJ BASIN ASSETS FROM BAYSWATER EXPLORATION AND PRODUCTION FOR APPROXIMATELY $600 MILLION * PRAIRIE OPERATING CO ( PROP ) - ACQUISITION PRICE $602.75 MILLION, INCLUDES CASH AND 5.2 MILLION SHARES * PRAIRIE OPERATING CO SAYS INCREASES 2025 PRODUCTION, REVENUE AND...
Copyright 2023-2026 - www.financetom.com All Rights Reserved